tiprankstipranks
Xcorporeal Inc (XCRP)
OTHER OTC:XCRP
US Market

Xcorporeal (XCRP) Financial Statements

2 Followers

Xcorporeal Financial Overview

Xcorporeal's market cap is currently $15.00. The company's EPS TTM is $; its P/E ratio is ―; Xcorporeal is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 08Dec 07Dec 06Dec 05Dec 04
Income Statement
Total Revenue
Gross Profit$ 0.00----
Operating Income$ -31.89M$ -18.26M$ -99.19K$ -177.63K$ -107.35K
EBITDA$ -31.79M$ -18.23M$ 151.10K$ -16.77K$ -47.35K
Net Income$ -22.99M$ -17.07M$ 5.33M$ -671.97K$ -4.23M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 4.35M$ 17.25M$ 27.54M$ 197.00$ 4.17K
Total Debt$ 0.00$ 0.00$ 16.80K$ 988.54K$ 947.34K
Net Debt$ -3.36M$ -16.51M$ -27.42M$ 988.35K$ 943.18K
Total Liabilities$ 6.39M$ 2.03M$ 2.13M$ 5.78M$ 5.38M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -12.91M$ -11.06M$ -46.29K$ -42.77K$ -225.83K
Operating Cash Flow$ -12.74M$ -10.77M$ -46.29K$ -42.77K$ -225.83K
Investing Cash Flow
Financing Cash Flow

Xcorporeal Earnings and Revenue History

Xcorporeal Debt to Assets

Xcorporeal Cash Flow

Xcorporeal Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.